The new Polish stent Chopin. Assessment of safety and efficacy in the treatment of de-novo coronary lesions using percutaneous angioplasty;Polski stent Chopin. Ocena skuteczności leczenia zmian de-novo w naczyniach wieńcowych metoda̧ przezskórnej angioplastyki

Kardiologia Polska

Volumn 62, Issue 5, 2005, Pages 451-461

  Buszman, Paweł ^a,c   Zurakowski, Aleksander ^a,c   Kinasz, Leszek ^b,d   Gorycki, Bogdan ^b,d   Król, Marek ^a,c   Lewicki, Andrzej ^a,c   Flak, Zbigniew ^a,c   Milewski, Krzysztof ^a,c   Zurek, Paweł ^a,c   Gil, Robert J ^e  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Department of Cardiology and Angiology ^*  (Poland)

^c Górno la ski O rodek Kardiologii   (Poland)

^d Oddzia Kardiologiczno Angiologiczny   (Poland)

^e CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

Author keywords

Coronary artery disease; Percutaneous coronary intervention; Stent

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; IMPLANTATION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVASCULARIZATION; SWINE; UNSTABLE ANGINA PECTORIS;

EID: 20444430443     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Holmes D.R., Berger P.B.: Complex intervention. W: Topol EJ red. Textbook of interventional cardiology. Saunders, Philadelphia 2003, 201.
2. Kutryk M.J.B., Serruys P.W.: Stents: The Menu. W: Topol EJ red. Textbook of interventional cardiology. Saunders, Philadelphia 2003, 591-630.
3. Chew D.P., Topol E.J.: Indications and limitations of Coronary Stenting. W: Topol EJ red. Textbook of interventional cardiology. Saunders, Philadelphia 2003, 631-647.
4. Serruys P.W., de Jaegere P., Kiemeneij F. et al., and The Benestent Study Group A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease N. Engl. J. Med. 1994, 331, 489-495.
5. Serruys P.W., van Hout B., Bonnier H. et al: Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998, 352, 673-81.
6. Fischman D.L., Leon M.B., Bairn D.S. et al: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: stent restenosis study investigators. N. Engl. J. Med. 1994, 331, 496-501.
7. Holmes D.R. Jr, Lansky A., Kuntz R. et al.: The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions. Am. J. Cardiol. 2000, 86, 1073-9.
8. Bairn D.S., Cutlip D.E., O'Shaughnessy C.D. et al.: NIRVANA Investigators (NIR Vascular Advanced North American Trial). Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am. J. Cardiol. 2001, 87, 152-6.
9. Jorgensen E., Kelbaek H., Helqvist W. et al.: Danish multicenter stent study (DANSTENT). Low restenosis rate of the NIR coronary stent: results of the Danish multicenter stent study (DANSTENT) - a randomized trial comparing a first-generation stent with a second-generation stent. Am. Heart J. 2003, 145, e5
10. Bairn D.S., Cutlip D.E., Midei M. et al., and ASCENT Invesigators (ACS MultLink Stent Clinical Equivalence in De Novo Lesions Trial). Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am. J. Cardiol. 2001, 87, 157-62.
11. Miketic, Carlsson J., Tebbe U.: Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty. Am. Heart J. 2001, 142, E8.
12. Cutlip D.E., Chauhan M.S., Bairn D.S. et al.: Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J. Am. Coll. Cardiol. 2002, 40, 2082-9.
13. Chan A.W., Moliterno D.J.: Restenosis: The Clinical Issues. W: Topol E.J. red. Textbook of Interventional Cardiology. Saunders, Philadelphia 2003, 422-429.
14. Tashiro H., Shimokawa H., Sadamatsu K. et al.: Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty. Coron. Artery Dis. 2001, 12, 107-113.
15. Zurakowski A., Dzielski T., Wojakowski W., Buszman P.: Wpływ zapalenia i insulinooporności na hiperplazjȩ neointimy w stencie i ryzyko restenozy. Kardiol. Pol. 2004, 61 (Suppl.III), III-22.